NEW YORK, May 30 (UPI) -- New York researchers find imaging suspicious breast lesions with magnetic resonance spectroscopy reduced the need for a breast-cancer biopsy by 58 percent.
Researchers at the Memorial Sloan-Kettering Cancer Center in New York discovered that with the addition of MR spectroscopy to their breast MR imaging, or MRI protocol, 23 of 40 suspicious lesions could have been spared biopsy, and none of the resultant cancers would have been missed, according to the study published in the June issue of Radiology.
"All cancers in this study were identified with MR spectroscopy. There were no false-negative results," said lead investigator Dr. Lia Bartella.
"With the addition of MR spectroscopy to our breast MRI exam, we found that the number of biopsies recommended on the basis of MRI findings decreased significantly. These results should encourage more women to take this potentially life-saving test."
